Evidence map›Paper›PMID 41634740›Full record

ArticleBMC medical informatics and decision making2026

Interpretable machine learning based decision-making system for lung adenocarcinoma metastasis: a population-based study with exploration of multi-classification models.

Jian Xu, Shuo Chen, Chang Zhao, Miao He, Feng Luo, Xintian Cai, Jiantao Wang, Zhendong Ding, TieWa Zhang

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jian Xu *Department of Oncology, Neijiang Second People's Hospital, No. 470 Xinjiang Road, , Neijiang, China.
Shuo Chen *Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.
Chang ZhaoDepartment of Pathology, Neijiang Second People's Hospital, No. 470 Xinjiang Road, Neijiang, 641000, China.
Miao HeDepartment of Oncology, Neijiang Second People's Hospital, No. 470 Xinjiang Road, , Neijiang, China.
Feng LuoDepartment of Oncology, Neijiang Second People's Hospital, No. 470 Xinjiang Road, , Neijiang, China.
Xintian CaiHeart, Lung and Vessels Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China.
Jiantao WangDepartment of Oncology, Neijiang Second People's Hospital, No. 470 Xinjiang Road, , Neijiang, China. wangjiantao@wchscu.cn.
Zhendong DingDepartment of Anesthesiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, China. dingzhd66@csu.edu.cn.ORCID 0000-0001-5178-8983
TieWa ZhangDepartment of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China. 810911@hrbmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate metastasis prediction in lung adenocarcinoma is essential for effective treatment plans and improved prognosis. Current methods face challenges in accuracy and clinical application.

methodsWe developed a binary classification model (XGBoost) and a multiclassification model (stacking) using SEER database data. The binary model predicts metastasis presence (M0 vs. non-M0), and the multiclassification model further refines the degree of metastasis (M1a, M1b, M1c). Model performance was assessed using ROC AUC, PR AUC, and KS curves. SHAP values were used to analyze important features and explain the decision-making process.

resultsThe binary model achieved ROC AUC and PR AUC scores exceeding 0.77, with the KS curve showing high consistency in distinguishing between positive and negative samples. The multiclassification model also performed well, demonstrating stability and generalizability across different metastasis stages. Key predictive factors included AJCC stage, survival duration, tumor size, and treatment information.

conclusionThis study improves the accuracy and clinical application of metastasis prediction in lung adenocarcinoma through interpretable machine learning models. The combination of binary and multiclassification models not only predicts metastasis presence but also details its extent, providing valuable clinical decision support. Future research should integrate diverse data sources to enhance model robustness and better serve clinical practice. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Adenocarcinoma of LungLung NeoplasmsMachine LearningNeoplasm MetastasisAgedClassification AlgorithmsFemaleHumansMaleMiddle AgedPredictive Learning ModelsSEER ProgramClinical decision supportInterpretable machine learningLung adenocarcinomaMetastatic extent predictionSHAP

Identifiers

PMID41634740
PMCPMC12955088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.